Clinical Study

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Of Oral Rpc1063 As Induction And Maintenance Therapy For Moderate To Severe

Posted Date: May 15, 2019

  • Investigator: Bruce Yacyshyn
  • Specialties:
  • Type of Study: Drug



You Have Been Asked To Join This Study Because You Are Being Treated For Moderate Or Severe Uc And Y


Inflammatory Bowel D, Ulcerative Colitis

For More Information:

Renee Henry

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.